Contact us
White Paper

Fill out this short form to download the white paper.

Download our white paper, with new research from ixlayer and Ipsos, exploring how consumer expectations for a digital ecosystem have become crucial for biopharmaceutical companies aiming to enhance patient engagement.

16%

Only 16% of survey respondents strongly agreed with the statement, “Pharma companies are patient centric and prioritize the needs and preferences of the patient.”¹

81%

of survey respondents strongly or somewhat agreed that pharmaceutical companies should provide resources to patients to help them get the care and medicines they need.²

92%

of survey respondents said they would have a much more improved or somewhat more improved perception of a pharma company that offers patient-centric digital health solutions.³

1 ixInsights 2025 / Ipsos Patient research, Bottom Box, Base All n=414 individuals with one of the following conditions: respiratory conditions, asthma, COPD, type 2 diabetes, heart disease, dermatologic conditions, psoriasis, or atopic dermatitis. – On a scale from 1 to 5, where 1 is strongly disagree and 5 is strongly agree, please rate how much you agree or disagree with the following statement: “Pharma companies are patient centric and prioritize the needs and preferences of the patient.”

2 ixInsights 2025 / Ipsos Patient research, Top 2 Box, Base All n=414 individuals with one of the following conditions: respiratory conditions, asthma, COPD, type 2 diabetes, heart disease, dermatologic conditions, psoriasis, or atopic dermatitis. – On a scale from 1 to 5, where 1 is strongly disagree and 5 is strongly agree, please rate how much you agree or disagree with the following statements: “Pharmaceutical companies should provide resources to patients to help them get the care and medicines they need.”

³ ixInsights 2025 / Ipsos Patient research, Top 2 Box, Base All n=414 individuals with one of the following conditions: respiratory conditions, asthma, COPD, type 2 diabetes, heart disease, dermatologic conditions, psoriasis, or atopic dermatitis. “If a pharma company were to offer a digital solution with the following attributes how, if at all, would it change your perception of the company?” Digital health solutions include any of the following: (1) Ability to consult with healthcare professionals virtually or schedule in person; (2) Easier access for lab testing; at home kits, or scheduling at service center; (3) Provides access to insurance benefits, claims and payment support; (4) Provides digital pharmacy options (e.g., online ordering, prescription delivery; (5) Telehealth options for primary and specialist healthcare providers.